Tetsuhide Ito

1.6k total citations
46 papers, 1.2k citations indexed

About

Tetsuhide Ito is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Tetsuhide Ito has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 30 papers in Surgery and 11 papers in Epidemiology. Recurrent topics in Tetsuhide Ito's work include Pancreatic and Hepatic Oncology Research (33 papers), Pancreatitis Pathology and Treatment (24 papers) and Neuroendocrine Tumor Research Advances (11 papers). Tetsuhide Ito is often cited by papers focused on Pancreatic and Hepatic Oncology Research (33 papers), Pancreatitis Pathology and Treatment (24 papers) and Neuroendocrine Tumor Research Advances (11 papers). Tetsuhide Ito collaborates with scholars based in Japan, United States and Canada. Tetsuhide Ito's co-authors include Masao Tanaka, Takao Ohtsuka, Kazuhiro Mizumoto, Shunichi Takahata, Noboru Ideno, Itsuro Nakano, Toshihiko Sumii, Keiichiro Ogoshi, Sachihiro Matsunaga and Osamu Yasuda and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Surgery.

In The Last Decade

Tetsuhide Ito

44 papers receiving 1.2k citations

Peers

Tetsuhide Ito
Tetsuhide Ito
Citations per year, relative to Tetsuhide Ito Tetsuhide Ito (= 1×) peers Koji Tsuruta

Countries citing papers authored by Tetsuhide Ito

Since Specialization
Citations

This map shows the geographic impact of Tetsuhide Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuhide Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuhide Ito more than expected).

Fields of papers citing papers by Tetsuhide Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuhide Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuhide Ito. The network helps show where Tetsuhide Ito may publish in the future.

Co-authorship network of co-authors of Tetsuhide Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuhide Ito. A scholar is included among the top collaborators of Tetsuhide Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuhide Ito. Tetsuhide Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyasaka, Yoshihiro, Takao Ohtsuka, Koji Tamura, et al.. (2015). Predictive Factors for the Metachronous Development of High-risk Lesions in the Remnant Pancreas After Partial Pancreatectomy for Intraductal Papillary Mucinous Neoplasm. Annals of Surgery. 263(6). 1180–1187. 51 indexed citations
2.
Kimura, Hideyo, Takao Ohtsuka, Taketo Matsunaga, et al.. (2015). Predictors and Diagnostic Strategies for Early-Stage Pancreatic Ductal Adenocarcinoma. Pancreas. 44(7). 1148–1154. 11 indexed citations
3.
Tamura, Koji, Takao Ohtsuka, Taketo Matsunaga, et al.. (2014). Assessment of clonality of multisegmental main duct intraductal papillary mucinous neoplasms of the pancreas based on GNAS mutation analysis. Surgery. 157(2). 277–284. 23 indexed citations
4.
Ohtsuka, Takao, Koji Tamura, Noboru Ideno, et al.. (2014). The role of ERCP in the era of EUS-FNA for preoperative cytological confirmation of resectable pancreatic ductal adenocarcinoma. Surgery Today. 44(10). 1887–1892. 18 indexed citations
5.
Ideno, Noboru, Takao Ohtsuka, Hiroshi Kono, et al.. (2013). Intraductal Papillary Mucinous Neoplasms of the Pancreas With Distinct Pancreatic Ductal Adenocarcinomas Are Frequently of Gastric Subtype. Annals of Surgery. 258(1). 141–151. 95 indexed citations
6.
Tamura, Koji, Takao Ohtsuka, Noboru Ideno, et al.. (2013). Treatment Strategy for Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas Based on the Assessment of Recurrence in the Remnant Pancreas After Resection. Annals of Surgery. 259(2). 360–368. 59 indexed citations
7.
Sue, Mariko, Akira Kawashima, Takeshi Akama, et al.. (2012). Thyroglobulin (Tg) activates MAPK pathway to induce thyroid cell growth in the absence of TSH, insulin and serum. Biochemical and Biophysical Research Communications. 420(3). 611–615. 12 indexed citations
8.
Ohtsuka, Takao, Hiroshi Kono, Yosuke Nagayoshi, et al.. (2011). An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas. Surgery. 151(1). 76–83. 56 indexed citations
9.
Igarashi, Hisato, Tetsuhide Ito, Terumasa Hisano, et al.. (2011). Paclitaxel-Based Chemotherapy for Advanced Pancreatic Cancer after Gemcitabine-Based Therapy Failure: A Case Series of 5 Patients. SHILAP Revista de lepidopterología. 4(3). 534–541. 3 indexed citations
10.
Abe, Yasunobu, Tetsuhide Ito, Eishi Baba, et al.. (2010). Nonmyeloablative allogeneic hematopoietic stem cell transplantation as immunotherapy for pancreatic cancer. Suizo. 25(1). 92–94.
11.
Ishigami, Kousei, Tsuyoshi Tajima, Akihiro Nishie, et al.. (2009). Differential diagnosis of groove pancreatic carcinomas vs. groove pancreatitis: Usefulness of the portal venous phase. European Journal of Radiology. 74(3). e95–e100. 44 indexed citations
12.
Igarashi, Hisato, Tetsuhide Ito, Ken Kawabe, et al.. (2008). Chemoradiotherapy with twice-weekly administration of low-dose gemcitabine for locally advanced pancreatic cancer. World Journal of Gastroenterology. 14(34). 5311–5311. 8 indexed citations
13.
Nagata, Shigenori, Koji Yamaguchi, Takahiro Inoue, et al.. (2007). Solid pancreatic hamartoma. Pathology International. 57(5). 276–280. 36 indexed citations
15.
Zhao, Haifeng, Tetsuhide Ito, Ken Kawabe, et al.. (2005). Anti-monocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats. Gut. 54(12). 1759–1767. 51 indexed citations
16.
Ito, Tetsuhide, Itsuro Nakano, Toshihiko Miyahara, et al.. (1997). Autoimmune Pancreatitis as a New Clinical Entity (Three Cases of Autoimmune Pancreatitis with Effective Steroid Therapy). Digestive Diseases and Sciences. 42(7). 1458–1468. 271 indexed citations
17.
Ono, Yasuhiro, Toshinari Kimura, Itsuro Nakano, et al.. (1996). Acute pancreatitis induced by hypercalcaemia associated with adult T‐cell leukaemia: A case report. Journal of Gastroenterology and Hepatology. 11(2). 193–195. 10 indexed citations
18.
Ito, Tetsuhide, Toshinari Kimura, Hiroya Yamaguchi, et al.. (1993). Acute Pancreatitis Induced by Cyclosporin A Under Stimulation of Pancreas by Caerulein. Pancreas. 8(6). 693–699. 10 indexed citations
19.
Kimura, Toshinari, Tetsuhide Ito, Toshihiko Sumii, & Hajime Nawata. (1992). Serum Protease Inhibitor Capacity for Elastase and the Severity of Pancreatitis. Pancreas. 7(6). 680–685. 6 indexed citations
20.
Funakoshi, Akihiro, Yukio Yamada, Tetsuhide Ito, et al.. (1991). Clinical Usefulness of Serum Phospholipase A2 Determination in Patients with Pancreatic Diseases. Pancreas. 6(5). 588–594. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026